Anavex Life Sciences Corp (AVXL)

[WilliamMunny]

In citing the under $5 restriction of the ATM, Hosai, are you alluding to the new vehicle announced last week (and, I believe, put into effect yesterday)?

While I suspect that ultimately there may indeed be some commercial value in buntanetap, I have not been tempted to participate in ANVS because of their weak financial condition. As Langostino said, there will be a lot of dilution in order to float this boat. Furthermore, I had figured the AD TLR might redeem what figures to be an even worse readout on PD, where the company acknowledged data issues at some of the trial sites, and the scrubbing of what it did get has taken months longer than expected (not the mention the endpoint changes requested by the FDA after the trial had started). So the asset may seem cheap, but there is little cash in the corporate till to exploit it, and the PD results may exacerbate the problem.